Recruiting
Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
NCT05956041
- Conditions
- Cutaneous T Cell Lymphoma, Fungoides Mycosis Sezary Syndrome, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States